UK markets open in 4 hours 15 minutes
NIKKEI 225
38,282.92 +8.87 (+0.02%) HANG SENG
18,015.45 +252.42 (+1.42%) CRUDE OIL
79.33 +0.33 (+0.42%) GOLD FUTURES
2,330.20 +19.20 (+0.83%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,681.41 -2,038.91 (-4.27%)
NAVCO Pharmaceuticals Inc. (NAV.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
At close: 03:54PM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 2.00M |
| Enterprise value | 2.27M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 515.60 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -42.76 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -63.16% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 0.1000 |
| 52-week low 3 | 0.0200 |
| 50-day moving average 3 | 0.0356 |
| 200-day moving average 3 | 0.0349 |
Share statistics
| Avg vol (3-month) 3 | 16.02k |
| Avg vol (10-day) 3 | 11k |
| Shares outstanding 5 | 57.07M |
| Implied shares outstanding 6 | 57.07M |
| Float 8 | 36.64M |
| % held by insiders 1 | 0.35% |
| % held by institutions 1 | 0.00% |
| Shares short (15 Apr 2024) 4 | 568 |
| Short ratio (15 Apr 2024) 4 | 0.01 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.00% |
| Shares short (prior month 29 Feb 2024) 4 | 173 |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -1.58M |
| Net income avi to common (ttm) | -2.32M |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 79.6k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 651.04k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.56 |
| Book value per share (mrq) | -0.00 |
Cash flow statement
| Operating cash flow (ttm) | -1.97M |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.